Clinical trials
Observational Genetic Predisposition to Disease trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
| Completed | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Cancer Research, United Kingdom | 3 |
| St Mary's University College | 2 |
| Arbor Research Collaborative for Health | 1 |
| Cervical Artery Dissections and Ischemic Stroke Patients - Consortium | 1 |
| King's College Hospital NHS Trust | 1 |
| NHS Greater Glasgow and Clyde | 1 |
| Oxford Brookes University | 1 |
| Royal Marsden NHS Foundation Trust | 1 |
| The Wellcome Sanger Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genetic Predisposition to Disease | 12 |
| Prostatic Neoplasms | 4 |
| AIDS-Associated Nephropathy | 1 |
| Brain Infarction | 1 |
| Cardiomyopathies | 1 |
| Cardiovascular Diseases | 1 |
| Carotid Artery, Internal, Dissection | 1 |
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 |
| Diabetes Mellitus | 1 |
| Genetic Risk Score | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.